MICHAEL E. CHAPMAN
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
None in current sources.
- MICHAEL E. CHAPMAN
- SHIRE PHARMACEUTICAL INVESTMENT HOLDINGS LIMITED· director of
- SHIRE PHARMACEUTICAL INVESTMENT LIMITED· director of
Nothing further is withheld here. The ownership and control links above are everything we have resolved for MICHAEL E. CHAPMAN — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.
Coverage of MICHAEL E. CHAPMAN is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.
Explore US coverage- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
- Full export (PDF + un-redacted JSON) & change alertsPREMIUM
People & control
2 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- SHIRE PHARMACEUTICAL INVESTMENT HOLDINGS LIMITEDAlso holds roles at 6 other companies
- MICHAEL C. SCHMIDTsecretary of
- JOHN MILLERdirector of
- JOHN MILLERlegal representative of
- SHIRE PHARMACEUTICAL INVESTMENT LIMITEDAlso holds roles at 6 other companies
- MICHAEL C. SCHMIDTsecretary of
- SHIRE PHARMACEUTICALS GROUPshareholder of
- JOHN MILLERdirector of
2 parties · 0 current. Ceased and resigned records are retained as history.